INS NYC 2024 Program

Custom Content

Poster Session 09 Program Schedule

02/16/2024
03:30 pm - 04:45 pm
Room: Shubert Complex (Posters 1-60)

Poster Session 09: Epilepsy | Oncology | MS | Infectious Disease


Final Abstract #1

Poster Symposium: Summary

Neuropsychology in the Era of SARS-CoV-2

Category: Other

Keyword 1: cognitive functioning
Keyword 2: cognitive rehabilitation
Keyword 3: infectious disease

Summary Abstract:

Objective: This symposium aims to raise awareness, clarify misconceptions, promote understanding, and provide guidelines and recommendations for neuropsychologists on the pathophysiology, assessment, clinical manifestations, management, and public health challenges related to the Post-Acute Sequelae of SARS-CoV-2 (PASC).

Methods: Leading experts in the field of neuropsychology who are at the forefront of research on PASC will discuss the latest findings, challenges, clinical guidelines, and future research avenues related to the neuropsychological consequences of PASC. This includes, 1) a general overview and background on PASC, the nuances in research methodology, and cross-cultural considerations, 2) preliminary data on the global dimensions of assessment COVID-19-related neurocognitive concerns and barriers to treatment, 3) a narrative review of neurocognitive outcomes in PASC and their association with laboratory-based biomarkers, 4) the promise of cognitive rehabilitation interventions for patients with PASC-related cognitive and psychiatric sequelae, and 5) the potential long-term risk and implications of PASC in relation to later neurodegeneration.

Conclusions: The COVID-19 pandemic has profoundly impacted cognitive and mental health at the population level, and PASC continues to pose an unprecedented public health burden. The number of patients with PASC is escalating, and the most commonly reported symptoms are a gradient of neuropsychiatric and cognitive sequelae, which have profound effects on patients’ functioning and quality of life. It is imperative that neuropsychologists stay up-to-date with the latest research on the cognitive and neuropsychiatric effects of PASC in order to improve clinical care and make advances in science globally.